Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1974-01-07
1976-05-25
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31165
Patent
active
039594866
ABSTRACT:
New 1-amino-3-carbamoylalkoxyphenoxypropan-2-ol derivatives, for example 1-t-butylamino-3-(o-N-methylcarbamoylmethoxyphenoxy)propane-2-ol, processes for their manufacture and pharmaceutical compositions containing them. The compounds possess .beta.-adrenergic blocking activity and are useful in the treatment of heart diseases and other conditions in man.
REFERENCES:
patent: 3466325 (1969-09-01), Brandstrom
patent: 3483221 (1969-12-01), Wilhelm et al.
patent: 3562297 (1971-02-01), Howe et al.
patent: 3574749 (1971-04-01), Howe et al.
patent: 3634511 (1972-01-01), Howe et al.
patent: 3641152 (1972-02-01), Shavel et al.
patent: 3663607 (1972-05-01), Barrett et al.
Le Count David James
Squire Christopher John
Imperial Chemical Industries Limited
Moyer Donald B.
LandOfFree
Method for producing .beta.-adrenergic blockage with alkanolamin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for producing .beta.-adrenergic blockage with alkanolamin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing .beta.-adrenergic blockage with alkanolamin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-906357